The
global Mammography Market is expected to reach a value of USD
3.8 billion by 2025, according to a new report by Grand View Research, Inc. The
market growth can be attributed to the rising initiatives by various
governments and NGOs to raise awareness about early diagnosis of
microcalcifications in breast tissue. Some significant organizations such as
the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are
promoting the early diagnosis of mammary gland calcification, which is one of
the crucial factors expected to drive the demand over the forecast period.
Based
on a report published by the National Cancer Institute in 2015, it was stated
that the proportion of women aged 45 to 65 years had increased to 81.1% in
breast cancer screening. Major mammography manufacturers are introducing new
products and increasing the number of approved products, which is further
expected to impel the demand in the coming years.
In
January 2016, FDA approved a new manual for digital mammography quality control
by the American College of Radiology. The growing number of awareness campaigns
to promote womens’ health services is also anticipated to propel growth.
Some
of the key industry players are Fujifilm; Hologic; Philips Healthcare; Siemens
Healthineers; Toshiba Medical Systems Corporation; GE Healthcare; Metaltronica;
PLANMED OY; Mindray Medical International Limited; and IMS srl.
Browse
Details of Report @
http://www.grandviewresearch.com/industry-analysis/mammography-market
http://www.grandviewresearch.com/industry-analysis/mammography-market
Further Key Findings From the Study Suggest:
- Digital
systems dominated the product segment in 2015 owing to the wide
availability of digital breast screening devices and presence of favorable
reimbursements for such devices
- Digital
mammography dominated the application segment in 2015 due to growing
awareness regarding digital technology and increasing adoption of such
technology for better diagnosis
- In 2015,
North America dominated due to the increasing adoption of technologically
advanced screening devices and up surging number of approvals of 3D
systems
- Asia Pacific
and Latin America are the two fastest growing regional segments, because
of the higher mammary gland cancer prevalence and growing number of
government campaigns to improve screening results
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment